Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin
Open Access
- 7 July 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 64 (3), 447-453
- https://doi.org/10.1093/jac/dkp245
Abstract
Parenteral antimicrobial therapy is traditionally offered in the inpatient setting in many parts of the world. In the USA, the past three decades have seen an unprecedented increase in the delivery of these therapies in the non-inpatient setting, and outpatient parenteral antibiotic therapy (OPAT) is now an established standard of care in North America. However, the uptake of OPAT within Europe has been more gradual, owing to a number of clinical, fiscal, logistical and cultural considerations. In particular, physicians who are not currently engaged in OPAT programmes frequently cite concerns over patient safety as a major barrier. However, where OPAT programmes have been established, high levels of satisfaction are reported by both patients and physicians, suggesting that many anxieties concerning the introduction of OPAT stem from a lack of patient and physician education regarding the key potential benefits associated with OPAT. As the burden of serious Gram-positive infections grows, so does the need to offer clinicians, administrators and patients alternative treatment programmes that are equally effective and safe compared with inpatient treatment, while promoting optimal use of limited healthcare resources. This article will review the European experience of OPAT, discussing the associated benefits and the potential antibiotic options, with an emphasis on the evolving experience with daptomycin.Keywords
This publication has 40 references indexed in Scilit:
- The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000–2006Clinical Microbiology & Infection, 2008
- An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT serviceJournal of Antimicrobial Chemotherapy, 2008
- Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 yearsJournal of Antimicrobial Chemotherapy, 2007
- Home Intravenous Antimicrobial Infusion Therapy: A Viable Option in Older AdultsJournal of the American Geriatrics Society, 2007
- Outpatient parenteral antibiotic therapy in SingaporeInternational Journal of Antimicrobial Agents, 2006
- Experience of Infectious Diseases Consultants with Outpatient Parenteral Antimicrobial Therapy: Results of an Emerging Infections Network SurveyClinical Infectious Diseases, 2006
- Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparisonInternational Journal of Antimicrobial Agents, 2004
- Practice Guidelines for Outpatient Parenteral Antimicrobial TherapyClinical Infectious Diseases, 2004
- Practice Guidelines for Community‐Based Parenteral Anti‐Infective TherapyClinical Infectious Diseases, 1997
- Surveillance of infection in home careAmerican Journal of Infection Control, 1992